Denali Therapeutics Inc.
NASDAQ:DNLI
14.1 (USD) • At close June 27, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2025 Q1 | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q4 | 2018 Q3 | 2018 Q2 | 2018 Q1 | 2017 Q4 | 2017 Q3 | 2017 Q2 | 2017 Q1 | 2016 Q4 | 2016 Q3 | 2016 Q2 | 2016 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0 | 0 | 0 | 0 | 0 | -305.043 | 1.267 | 294.123 | 35.141 | 10.283 | 3.559 | 52.48 | 42.141 | 12.514 | 5.285 | 22.939 | 7.923 | 316.815 | 9.393 | 5.847 | 3.604 | 4.672 | 13.604 | 4.197 | 4.205 | 125.676 | 1.195 | 1.648 | 0.641 | 145.149 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 0 | 0 | 0 | 1.942 | 2.162 | 2.177 | 2.217 | 1.357 | 9.17 | 3.228 | 1.276 | 1.232 | 1.296 | 1.311 | 71.559 | 65.711 | 60.207 | 54.743 | 53.704 | 53.152 | 51.016 | 51.551 | 52.544 | 51.884 | 37.403 | 39.909 | 30.321 | 52.134 | 20.819 | 18.471 | 18.515 | 19.004 | 18.47 | 0 | 0 | 0 | 0 |
| Gross Profit
| 0 | 0 | 0 | -1.942 | -2.162 | -307.22 | -0.95 | 292.766 | 25.971 | 7.055 | 2.283 | 51.248 | 40.845 | 11.203 | -66.274 | -42.772 | -52.284 | 262.072 | -44.311 | -47.305 | -47.412 | -46.879 | -38.94 | -47.687 | -33.198 | 85.767 | -29.126 | -50.486 | -20.178 | 126.678 | -18.515 | -19.004 | -18.47 | 0 | 0 | 0 | 0 |
| Gross Profit Ratio
| 0 | 0 | 0 | 0 | 0 | 1.007 | -0.75 | 0.995 | 0.739 | 0.686 | 0.641 | 0.977 | 0.969 | 0.895 | -12.54 | -1.865 | -6.599 | 0.827 | -4.717 | -8.09 | -13.155 | -10.034 | -2.862 | -11.362 | -7.895 | 0.682 | -24.373 | -30.635 | -31.479 | 0.873 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 116.227 | 99.787 | 98.238 | 91.399 | 107.016 | 107.803 | 89.737 | 97.52 | 128.816 | 92.111 | 87.786 | 92.737 | 86.098 | 67.876 | 71.559 | 65.711 | 60.207 | 54.743 | 53.704 | 53.152 | 51.016 | 51.551 | 52.544 | 51.884 | 37.403 | 39.909 | 30.321 | 52.134 | 20.819 | 18.471 | 18.515 | 19.004 | 18.47 | 16.73 | 27.819 | 15.577 | 15.577 |
| General & Administrative Expenses
| 29.353 | 30.059 | 24.949 | 25.194 | 25.236 | 24.769 | 25.325 | 26.12 | 27.14 | 23.516 | 23.259 | 21.159 | 22.541 | 21.759 | 19.319 | 19.045 | 18.936 | 17.994 | 15.805 | 13.972 | 12.555 | 10.879 | 11.215 | 15.076 | 9.31 | 11.045 | 8.838 | 6.896 | 5.57 | 5.069 | 3.773 | 3.564 | 3.274 | 3.046 | 3.113 | 2.786 | 2.786 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | -1.942 | -2.162 | -2.177 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 29.353 | 30.059 | 24.949 | 23.252 | 23.074 | 22.592 | 25.325 | 26.12 | 27.14 | 23.516 | 23.259 | 21.159 | 22.541 | 21.759 | 19.319 | 19.045 | 18.936 | 17.994 | 15.805 | 13.972 | 12.555 | 10.879 | 11.215 | 15.076 | 9.31 | 11.045 | 8.838 | 6.896 | 5.57 | 5.069 | 3.773 | 3.564 | 3.274 | 3.046 | 3.113 | 2.786 | 2.786 |
| Other Expenses
| 0 | 0 | 0 | -14.364 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 145.58 | 129.846 | 123.187 | 114.651 | 130.09 | 130.395 | 115.062 | 123.64 | 155.956 | 115.627 | 111.045 | 113.896 | 108.639 | 89.635 | 90.878 | 84.756 | 79.143 | 72.737 | 69.509 | 67.124 | 63.571 | 62.43 | 63.759 | 66.96 | 46.713 | 50.954 | 39.159 | 59.03 | 26.389 | 23.54 | 22.288 | 22.568 | 21.744 | 19.776 | 30.932 | 18.362 | 18.362 |
| Operating Income
| -145.58 | -129.846 | -123.187 | -116.593 | -132.252 | -132.572 | -113.795 | 170.483 | -120.815 | -105.344 | -107.486 | -61.416 | -66.498 | -77.121 | -85.593 | -61.817 | -71.22 | 244.078 | -60.116 | -61.277 | -59.967 | -57.758 | -50.155 | -62.763 | -42.508 | 74.722 | -37.964 | -57.382 | -25.748 | -23.54 | -22.288 | -22.568 | -21.744 | -19.866 | -25.632 | -18.363 | -18.363 |
| Operating Income Ratio
| 0 | 0 | 0 | 0 | 0 | 0.435 | -89.815 | 0.58 | -3.438 | -10.244 | -30.201 | -1.17 | -1.578 | -6.163 | -16.195 | -2.695 | -8.989 | 0.77 | -6.4 | -10.48 | -16.639 | -12.363 | -3.687 | -14.954 | -10.109 | 0.595 | -31.769 | -34.819 | -40.168 | -0.162 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| 12.61 | 15.161 | 15.995 | 17.567 | 15.913 | 13.129 | 14.442 | 12.9 | 11.034 | 6.66 | 4.187 | 2.649 | 1.278 | 1.285 | 1.005 | 1.126 | 1.179 | 1.63 | 1.944 | 2.598 | 3.069 | 3.808 | 3.782 | 4.113 | 3.516 | 2.811 | 2.593 | 2.658 | 2.07 | 0.653 | 0.444 | 0.434 | 0.424 | 0.512 | 0.231 | 0.019 | 0.019 |
| Income Before Tax
| -132.97 | -114.685 | -107.192 | -99.026 | -101.802 | -119.443 | -99.353 | 183.383 | -109.781 | -98.684 | -103.299 | -58.767 | -65.22 | -75.836 | -84.588 | -60.691 | -70.041 | 245.708 | -58.172 | -58.679 | -56.898 | -53.95 | -46.373 | -58.65 | -38.992 | 77.533 | -35.371 | -54.724 | -23.678 | -22.887 | -21.844 | -22.134 | -21.32 | -19.354 | -30.611 | -18.344 | -18.344 |
| Income Before Tax Ratio
| 0 | 0 | 0 | 0 | 0 | 0.392 | -78.416 | 0.623 | -3.124 | -9.597 | -29.025 | -1.12 | -1.548 | -6.06 | -16.005 | -2.646 | -8.84 | 0.776 | -6.193 | -10.036 | -15.787 | -11.548 | -3.409 | -13.974 | -9.273 | 0.617 | -29.599 | -33.206 | -36.939 | -0.158 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| 0 | 0.068 | 0 | 0 | 2.119 | 0.03 | 2.257 | -2.285 | -10.047 | -0.006 | 2.114 | 0.027 | -1.278 | -0.575 | 0.782 | 0.728 | -2.108 | 0.823 | 0.056 | 0.079 | -0.135 | 0.075 | -0.113 | -0.313 | 0 | -2.379 | 0 | 0 | 0 | -0.807 | 0 | 0 | 0 | 0.09 | 0 | 0 | 0 |
| Net Income
| -132.97 | -114.753 | -107.192 | -99.026 | -101.802 | -119.473 | -99.353 | 183.383 | -109.781 | -98.678 | -103.299 | -58.794 | -63.942 | -75.261 | -84.588 | -60.691 | -70.041 | 244.885 | -58.228 | -58.758 | -56.763 | -54.025 | -46.26 | -58.337 | -38.992 | 77.533 | -35.371 | -54.724 | -23.678 | -22.887 | -21.844 | -22.134 | -21.32 | -19.354 | -30.611 | -18.344 | -18.344 |
| Net Income Ratio
| 0 | 0 | 0 | 0 | 0 | 0.392 | -78.416 | 0.623 | -3.124 | -9.596 | -29.025 | -1.12 | -1.517 | -6.014 | -16.005 | -2.646 | -8.84 | 0.773 | -6.199 | -10.049 | -15.75 | -11.564 | -3.4 | -13.9 | -9.273 | 0.617 | -29.599 | -33.206 | -36.939 | -0.158 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS
| -0.78 | -0.67 | -0.63 | -0.59 | -0.68 | -0.86 | -0.72 | 1.34 | -0.8 | -0.74 | -0.84 | -0.48 | -0.52 | -0.62 | -0.69 | -0.5 | -0.58 | 2.04 | -0.54 | -0.56 | -0.55 | -0.57 | -0.48 | -0.61 | -0.41 | 0.82 | -0.38 | -0.59 | -0.26 | -0.74 | -0.27 | -0.32 | -2.36 | -2.15 | -4.51 | -3.37 | -3.37 |
| EPS Diluted
| -0.78 | -0.67 | -0.63 | -0.59 | -0.68 | -0.86 | -0.72 | 1.3 | -0.8 | -0.74 | -0.84 | -0.48 | -0.52 | -0.62 | -0.69 | -0.49 | -0.58 | 1.91 | -0.54 | -0.56 | -0.55 | -0.56 | -0.48 | -0.61 | -0.41 | 0.79 | -0.38 | -0.59 | -0.26 | -0.74 | -0.27 | -0.32 | -2.36 | -2.15 | -4.51 | -3.37 | -3.37 |
| EBITDA
| -142.368 | -127.227 | -120.918 | -114.651 | -130.09 | -130.366 | -111.578 | 170.483 | -110.768 | -101.253 | -105.345 | -59.344 | -64.419 | -77.121 | -83.406 | -59.613 | -69.112 | 246.199 | -57.96 | -59.132 | -57.858 | -55.703 | -48.265 | -61.12 | -40.105 | 77.101 | -35.637 | -55.527 | -24.894 | -22.733 | -21.51 | -21.802 | -21.013 | -19.11 | -25.231 | -18.172 | -18.172 |
| EBITDA Ratio
| 0 | 0 | 0 | 0 | 0 | 0.427 | -88.065 | 0.58 | -3.152 | -9.847 | -29.6 | -1.131 | -1.529 | -6.163 | -15.782 | -2.599 | -8.723 | 0.777 | -6.171 | -10.113 | -16.054 | -11.923 | -3.548 | -14.563 | -9.537 | 0.613 | -29.822 | -33.694 | -38.836 | -0.157 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |